Beovu and Risk of Intraocular Inflammation – National PBM Bulletin

Mar 4, 2020 | Optometry HQ Announcements

Please see the attached bulletin: Beovu and Risk of Intraocular Inflammation_NATIONAL PBM BULLETIN_FINAL_022720_with disclaimer (002)


  • Facility Director (or physician designee): Forward this document to the Facility Chief of Staff (COS).
  • Facility COS and Chief Nurse Executives: Forward this document to all appropriate providers and health care staff (e.g., Ophthalmologists and Pharmacists, including contract providers, etc.).  In addition, forward to the Associate Chief of Staff (ACOS) for Research and Development (R&D). Forward to other VA employees as deemed appropriate. 
  • ACOS for R&D: Forward this document to Principal Investigators (PIs) who have authority to practice at the facility and to your respective Institutional Review Board (IRB).